Cite
HARVARD Citation
Rizzo, M. et al. (2015). Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study. Future oncology. pp. 219-224. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rizzo, M. et al. (2015). Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study. Future oncology. pp. 219-224. [Online].